| Application no. and date | 00985495.1 (espacenet) (Federated) (European Patent Register), 20001208 | | Patent/reg. no. and date | DK/EP 1235788, 20050330 | | Publication date | 20020904 | | Priority no. and date | GB 9929297, 19991211 | | EP pub. no. and date |
EP 1235788 20020904 | | Effective date | | | Applicant/owner | GLAXO GROUP LIMITED, Glaxo Wellcome House
Berkeley Avenue
Greenford, Middlesex UB6 ONN, GB | | Applicant ref. no. | P200500420 EP DK | | Inventor | LAWRENCE, Ronnie, Maxwell
Glaxo Wellcome plc, Gunnels Wood Road
Stevenage
Hertfordshire SG1 2NY, GB,
MILLAR, Alan
Smithkline Beecham Corporation, Five Moore Drive
Research Triangle Park, NC 27709, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/24 (2006.01) , A61K 31/44 (2006.01) , A61P 3/04 (2006.01) , A61P 3/10 (2006.01) , C07C 229/52 (2006.01) , C07C 237/06 (2006.01) , C07D 213/80 (2006.01) | | Title | Fremgangsmåde til fremstilling arylethanolaminderivater, der har anti-obesitas- og antidiabetiske egenskaber | | Int. application no. | GB2000004697 | | Int. publication no. | WO2001042195 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
